Renal denervation: What happened, and why?
Where this comes from
- Record sourced from PubMed, PMID 28885911.
- Also identified by DOI 10.3949/ccjm.84a.14129.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite promising results in initial trials, renal denervation failed to achieve its efficacy end points as a treatment for resistant hypertension in the SYMPLICITY HTN-3 trial, the largest trial of this treatment to date (N Engl J Med 2014; 370:1393-1401). Is renal denervation dead, or will future trials and newer technology revive it?
Medical subject headings
- Blood Pressure
- Denervation